{
  "ptid_time": "036_S_4715_2012-07-02",
  "img_path": "/data/qiuhui/data/adni/images/036_S_4715/2012-07-02/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 18,788 mm³, 0.9% above the reference mean. With a Z-score of 0.03 (51.0th percentile), this represents normal volume ; hippocampal volume measures 6,702 mm³, 14.2% below the reference mean. With a Z-score of -1.97 (2.4th percentile), this represents moderate atrophy; whole brain volume measures 946,942 mm³, 9.0% below the reference mean. With a Z-score of -1.08 (14.0th percentile), this represents mild atrophy; entorhinal cortex volume measures 2,319 mm³, 37.2% below the reference mean. With a Z-score of -2.91 (0.2th percentile), this represents significant atrophy; fusiform gyrus volume measures 17,273 mm³, 6.3% below the reference mean. With a Z-score of -0.57 (28.4th percentile), this represents normal volume ; middle temporal gyrus volume measures 19,361 mm³, 5.7% below the reference mean. With a Z-score of -0.47 (31.9th percentile), this represents normal volume . ",
  "text_data": "Age is 56.7 years. Gender is Female. Education: 18 years. Handedness: Right. Race: White. Medical history: Neurologic; Head, Eyes, Ears, Nose and Throat; Endocrine-Metabolic; Allergies or Drug Sensitivities; Malignancy; Major Surgical Procedures. MMSE: 25.0. MoCA: 22.0. Logical Memory: 2.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.20 SUVR (normal ); Amyloid beta: 1009.00 pg/mL (normal ); Total tau: 614.80 pg/mL (profound elevated); Phosphorylated tau: 64.50 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient shows significant atrophy in the hippocampus and entorhinal cortex, which are key regions affected in Alzheimer's disease (AD). Elevated T-tau and P-tau with normal Aβ and AV45 suggest a non-amyloid tauopathy, possibly primary age-related tauopathy (PART) or another tau-driven neurodegenerative process. The cognitive scores (MMSE 25, MoCA 22) indicate mild cognitive impairment (MCI).  \n\n**Diagnosis:** **MCI** (likely due to underlying tauopathy, not classic AD given normal Aβ).  \n**Confidence:** **Medium** (atypical biomarker profile raises uncertainty about exact etiology).",
  "timestamp": "2025-07-26T06:16:59.376969"
}